ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers February 15, 2023
2 Women-Founded Companies are Optimizing Targeted Lipid Nanoparticle mRNA Therapies for a Rare Respiratory DiseaseFebruary 3, 2023
Press Release Goodwin Welcomes Life Sciences….By Biotech Metropolitan WomenSeptember 17, 2019Goodwin Welcomes Life Sciences Licensing and Collaboration Partner Lily Wound in New York September 12, 2019 11:18 AM Eastern Daylight… Read More
Press Release Rgenix Names Industry Veteran to Chief Medical Officer RoleBy Biotech Metropolitan WomenSeptember 17, 2019Robert Wasserman, MD, joins Rgenix with more than 20 years of oncology clinical development experience and prior senior roles in… Read More
Press Release Medidata and Mapi Research Trust CollaborationBy Biotech Metropolitan WomenSeptember 14, 2019September 12, 2019 08:30 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Medidata (NASDAQ: MDSO) and Mapi Research Trust today announced a… Read More
Press Release Versant Ventures Enables Launch of Vensana Capital to Focus on Medtech SectorBy Biotech Metropolitan WomenSeptember 9, 2019September 04, 2019 08:00 AM Eastern Daylight Time SAN FRANCISCO & NEW YORK & VANCOUVER, British Columbia & BASEL, Switzerland–(BUSINESS… Read More
Press Release Bayer acquires BlueRock Therapeutics to build leading position in cell therapyBy Biotech Metropolitan WomenAugust 12, 2019Implied total company value of up to USD 1 billion, inclusive of 40.8 percent stake currently held by Bayer /… Read More
